Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $11.9 million.

  • Ekso Bionics Holdings' Total Non-Current Liabilities fell 1620.57% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year decrease of 1620.57%. This contributed to the annual value of $13.8 million for FY2024, which is 1368.37% down from last year.
  • Per Ekso Bionics Holdings' latest filing, its Total Non-Current Liabilities stood at $11.9 million for Q3 2025, which was down 1620.57% from $12.1 million recorded in Q2 2025.
  • Ekso Bionics Holdings' Total Non-Current Liabilities' 5-year high stood at $16.1 million during Q2 2023, with a 5-year trough of $8.1 million in Q2 2022.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $13.8 million (2024), whereas its average is $12.6 million.
  • Per our database at Business Quant, Ekso Bionics Holdings' Total Non-Current Liabilities tumbled by 2237.53% in 2021 and then skyrocketed by 9744.47% in 2023.
  • Ekso Bionics Holdings' Total Non-Current Liabilities (Quarter) stood at $10.4 million in 2021, then surged by 46.47% to $15.2 million in 2022, then increased by 4.71% to $15.9 million in 2023, then dropped by 13.68% to $13.8 million in 2024, then dropped by 13.71% to $11.9 million in 2025.
  • Its Total Non-Current Liabilities was $11.9 million in Q3 2025, compared to $12.1 million in Q2 2025 and $14.5 million in Q1 2025.